Nancy J Butcher - Publications

Affiliations: 
University of Toronto, Toronto, ON, Canada 
Area:
Neuroscience

83 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Pugliese M, Tingley K, Chow A, Pallone N, Smith M, Chakraborty P, Geraghty MT, Irwin JK, Mitchell JJ, Stockler S, Nicholls SG, Offringa M, Rahman A, Tessier LA, Butcher NJ, et al. Core Outcome Sets for Medium-Chain Acyl-CoA Dehydrogenase Deficiency and Phenylketonuria. Pediatrics. PMID 34266901 DOI: 10.1542/peds.2020-037747  0.01
2021 Sønderby IE, Ching CRK, Thomopoulos SI, van der Meer D, Sun D, Villalon-Reina JE, Agartz I, Amunts K, Arango C, Armstrong NJ, Ayesa-Arriola R, Bakker G, Bassett AS, Boomsma DI, Bülow R, ... Butcher NJ, et al. Effects of copy number variations on brain structure and risk for psychiatric illness: Large-scale studies from the ENIGMA working groups on CNVs. Human Brain Mapping. PMID 33615640 DOI: 10.1002/hbm.25354  1
2020 Knaapen M, Hall NJ, Moulin D, van der Lee JH, Butcher NJ, Minneci PC, Svensson JF, St Peter SD, Adams S, Nah SA, Skarsgard ED, Zani A, Emil S, Suominen JS, Aziz DA, et al. International Core Outcome Set for Acute Simple Appendicitis in Children: Results of A Systematic Review, Delphi Study, and Focus Groups with Young People. Annals of Surgery. PMID 33630468 DOI: 10.1097/SLA.0000000000004707  0.01
2020 Algurén B, Ramirez JP, Salt M, Sillett N, Myers SN, Alvarez-Cote A, Butcher NJ, Caneo LF, Cespedes JA, Chaplin JE, Ng KC, García-García JJ, Hazelzet JA, Klassen AF, Turquetto ALR, et al. Development of an international standard set of patient-centred outcome measures for overall paediatric health: a consensus process. Archives of Disease in Childhood. PMID 33310707 DOI: 10.1136/archdischild-2020-320345  0.01
2020 Stallwood E, Monsour A, Rodrigues C, Monga S, Terwee C, Offringa M, Butcher NJ. Systematic Review: The Measurement Properties of the Children's Depression Rating Scale-Revised in Adolescents With Major Depressive Disorder. Journal of the American Academy of Child and Adolescent Psychiatry. PMID 33130251 DOI: 10.1016/j.jaac.2020.10.009  0.01
2020 Monga S, Monsour A, Stallwood E, Desai R, Cleverley K, Courtney D, Henderson J, Korczak D, Krause K, Smith M, Szatmari P, Offringa M, Butcher N. Core Outcome Set Development for Adolescent Major Depressive Disorder Clinical Trials: A Registered Report. Journal of the American Academy of Child and Adolescent Psychiatry. 59: 1297-1298. PMID 33126995 DOI: 10.1016/J.Jaac.2020.07.905  0.01
2020 Butcher NJ, Mew EJ, Monsour A, Szatmari P, Monga S, Offringa M. Response to "Trials for depressive disorder in adolescents: the emperor's new clothes," a letter to the editor by Alain Braillon, MD, PhD. Journal of Clinical Epidemiology. PMID 32860976 DOI: 10.1016/J.Jclinepi.2020.08.010  0.01
2020 Butcher NJ, Mew EJ, Monsour A, Chan AW, Moher D, Offringa M. Outcome reporting recommendations for clinical trial protocols and reports: a scoping review. Trials. 21: 620. PMID 32641085 DOI: 10.1186/S13063-020-04440-W  0.01
2020 Mew EJ, Monsour A, Saeed L, Santos L, Patel S, Courtney DB, Watson PN, Szatmari P, Offringa M, Monga S, Butcher NJ. Systematic scoping review identifies heterogeneity in outcomes measured in adolescent depression clinical trials. Journal of Clinical Epidemiology. PMID 32561367 DOI: 10.1016/J.Jclinepi.2020.06.013  0.01
2020 Monsour A, Mew EJ, Patel S, Chee-A-Tow A, Saeed L, Santos L, Courtney DB, Watson PN, Monga S, Szatmari P, Offringa M, Butcher NJ. Primary outcome reporting in adolescent depression clinical trials needs standardization. Bmc Medical Research Methodology. 20: 129. PMID 32450810 DOI: 10.1186/S12874-020-01019-6  0.01
2020 Monga S, Offringa M, Butcher NJ, Szatmari P. From Research to Practice: The Importance of Appropriate Outcome Selection, Measurement, and Reporting in Pediatric Mental Health Research. Journal of the American Academy of Child and Adolescent Psychiatry. 59: 497-500. PMID 32220402 DOI: 10.1016/J.Jaac.2019.08.468  0.01
2020 Chan W, Thurairajah P, Butcher N, Oosterwijk C, Wever K, Eichler I, Thompson C, Junker A, Offringa M, Preston J. Guidance on development and operation of Young Persons' Advisory Groups. Archives of Disease in Childhood. PMID 32209556 DOI: 10.1136/archdischild-2019-318517  0.01
2020 Ching CRK, Gutman BA, Sun D, Villalon Reina J, Ragothaman A, Isaev D, Zavaliangos-Petropulu A, Lin A, Jonas RK, Kushan L, Pacheco-Hansen L, Vajdi A, Forsyth JK, Jalbrzikowski M, Bakker G, ... ... Butcher NJ, et al. Mapping Subcortical Brain Alterations in 22q11.2 Deletion Syndrome: Effects of Deletion Size and Convergence With Idiopathic Neuropsychiatric Illness. The American Journal of Psychiatry. appiajp201919060583. PMID 32046535 DOI: 10.1176/Appi.Ajp.2019.19060583  1
2020 Cleynen I, Engchuan W, Hestand MS, Heung T, Holleman AM, Johnston HR, Monfeuga T, McDonald-McGinn DM, Gur RE, Morrow BE, Swillen A, Vorstman JAS, Bearden CE, Chow EWC, van den Bree M, ... ... Butcher NJ, et al. Genetic contributors to risk of schizophrenia in the presence of a 22q11.2 deletion. Molecular Psychiatry. PMID 32015465 DOI: 10.1038/S41380-020-0654-3  1
2020 Pugliese M, Tingley K, Chow A, Pallone N, Smith M, Rahman A, Chakraborty P, Geraghty MT, Irwin J, Tessier L, Nicholls SG, Offringa M, Butcher NJ, Iverson R, Clifford TJ, et al. Outcomes in pediatric studies of medium-chain acyl-coA dehydrogenase (MCAD) deficiency and phenylketonuria (PKU): a review. Orphanet Journal of Rare Diseases. 15: 12. PMID 31937333 DOI: 10.1186/S13023-019-1276-1  0.01
2020 Ding S, Mew EJ, Chee-A-Tow A, Offringa M, Butcher NJ, Moore GP. Neurodevelopmental outcome descriptions in cohorts of extremely preterm children. Archives of Disease in Childhood. Fetal and Neonatal Edition. PMID 31932362 DOI: 10.1136/Archdischild-2019-318144  0.01
2019 Butcher NJ, Tricco AC, Offringa M, Moher D, Galica J. Training researchers in publication science: Why, what, and how. Journal of Clinical Epidemiology. PMID 31465843 DOI: 10.1016/J.Jclinepi.2019.08.007  0.01
2019 Zinkstok JR, Boot E, Bassett AS, Hiroi N, Butcher NJ, Vingerhoets C, Vorstman JAS, van Amelsvoort TAMJ. Neurobiological perspective of 22q11.2 deletion syndrome. The Lancet. Psychiatry. PMID 31395526 DOI: 10.1016/S2215-0366(19)30076-8  1
2019 Joachim KC, Farid-Kapadia M, Butcher NJ, Chee-A-Tow A, Monsour A, Cohen E, Mahant S, Guttmann A, Offringa M. Core outcome set for children with neurological impairment and tube feeding. Developmental Medicine and Child Neurology. PMID 31372989 DOI: 10.1111/Dmcn.14326  0.01
2019 Szatmari P, Offringa M, Butcher NJ, Monga S. Counting What Counts: The Case for Harmonized Outcomes in Child and Youth Mental Health Research. Journal of the American Academy of Child and Adolescent Psychiatry. 58: 656-658. PMID 31229181 DOI: 10.1016/J.Jaac.2019.02.016  0.01
2019 Knaapen M, Hall NJ, van der Lee JH, Butcher NJ, Offringa M, Van Heurn EWE, Bakx R, Gorter RR. Establishing a core outcome set for treatment of uncomplicated appendicitis in children: study protocol for an international Delphi survey. Bmj Open. 9: e028861. PMID 31123006 DOI: 10.1136/Bmjopen-2018-028861  0.01
2019 Butcher NJ, Monsour A, Mew EJ, Szatmari P, Pierro A, Kelly LE, Farid-Kapadia M, Chee-A-Tow A, Saeed L, Monga S, Ungar W, Terwee CB, Vohra S, Fergusson D, Askie LM, et al. Improving outcome reporting in clinical trial reports and protocols: study protocol for the Instrument for reporting Planned Endpoints in Clinical Trials (InsPECT). Trials. 20: 161. PMID 30841935 DOI: 10.1186/S13063-019-3248-0  0.01
2019 Butcher NJ, Mew EJ, Saeed L, Monsour A, Chee-A-Tow A, Chan AW, Moher D, Offringa M. Guidance for reporting outcomes in clinical trials: scoping review protocol. Bmj Open. 9: e023001. PMID 30782872 DOI: 10.1136/Bmjopen-2018-023001  0.01
2019 Monsour A, Mew EJ, Szatmari P, Patel S, Saeed L, Offringa M, Butcher NJ. Outcomes reported in randomised clinical trials of major depressive disorder treatments in adolescents: a systematic scoping review protocol. Bmj Open. 9: e024191. PMID 30782729 DOI: 10.1136/Bmjopen-2018-024191  0.01
2018 Galica J, Chee-A-Tow A, Gupta S, Jaiswal A, Monsour A, Tricco AC, Cobey KD, Butcher NJ. Learning best-practices in journalology: course description and attendee insights into the inaugural EQUATOR Canada Publication School. Bmc Proceedings. 12: 18. PMID 30540288 DOI: 10.1186/S12919-018-0155-4  0.01
2018 Kelly LE, Dyson MP, Butcher NJ, Balshaw R, London AJ, Neilson CJ, Junker A, Mahmud SM, Driedger SM, Wang X. Considerations for adaptive design in pediatric clinical trials: study protocol for a systematic review, mixed-methods study, and integrated knowledge translation plan. Trials. 19: 572. PMID 30340624 DOI: 10.1186/S13063-018-2934-7  0.01
2018 Sumitomo A, Horike K, Hirai K, Butcher N, Boot E, Sakurai T, Nucifora FC, Bassett AS, Sawa A, Tomoda T. A mouse model of 22q11.2 deletions: Molecular and behavioral signatures of Parkinson's disease and schizophrenia. Science Advances. 4: eaar6637. PMID 30116778 DOI: 10.1126/Sciadv.Aar6637  1
2018 Fiksinski AM, Breetvelt EJ, Lee YJ, Boot E, Butcher N, Palmer L, Chow EWC, Kahn RS, Vorstman JAS, Bassett AS. Neurocognition and adaptive functioning in a genetic high risk model of schizophrenia. Psychological Medicine. 1-8. PMID 30064532 DOI: 10.1017/S0033291718001824  1
2018 Sun D, Ching CRK, Lin A, Forsyth JK, Kushan L, Vajdi A, Jalbrzikowski M, Hansen L, Villalon-Reina JE, Qu X, Jonas RK, van Amelsvoort T, Bakker G, Kates WR, Antshel KM, ... ... Butcher NJ, et al. Large-scale mapping of cortical alterations in 22q11.2 deletion syndrome: Convergence with idiopathic psychosis and effects of deletion size. Molecular Psychiatry. PMID 29895892 DOI: 10.1038/S41380-018-0078-5  1
2018 Butcher NJ, Boot E, Lang AE, Andrade D, Vorstman J, McDonald-McGinn D, Bassett AS. Neuropsychiatric expression and catatonia in 22q11.2 deletion syndrome: An overview and case series. American Journal of Medical Genetics. Part A. PMID 29777584 DOI: 10.1002/Ajmg.A.38708  1
2018 Boot E, Butcher NJ, Udow S, Marras C, Mok KY, Kaneko S, Barrett MJ, Prontera P, Berman BD, Masellis M, Dufournet B, Nguyen K, Charles P, Mutez E, Danaila T, et al. Typical features of Parkinson disease and diagnostic challenges with microdeletion 22q11.2. Neurology. PMID 29752303 DOI: 10.1212/Wnl.0000000000005660  1
2018 Palmer LD, Butcher NJ, Boot E, Hodgkinson KA, Heung T, Chow EWC, Guna A, Crowley TB, Zackai E, McDonald-McGinn DM, Bassett AS. Elucidating the diagnostic odyssey of 22q11.2 deletion syndrome. American Journal of Medical Genetics. Part A. 176: 936-944. PMID 29575622 DOI: 10.1002/Ajmg.A.38645  1
2017 Wither RG, Borlot F, MacDonald A, Butcher NJ, Chow EWC, Bassett AS, Andrade DM. 22q11.2 deletion syndrome lowers seizure threshold in adult patients without epilepsy. Epilepsia. PMID 28448680 DOI: 10.1111/Epi.13748  1
2017 Butcher NJ, Merico D, Zarrei M, Ogura L, Marshall CR, Chow EWC, Lang AE, Scherer SW, Bassett AS. Whole-genome sequencing suggests mechanisms for 22q11.2 deletion-associated Parkinson's disease. Plos One. 12: e0173944. PMID 28430790 DOI: 10.1371/Journal.Pone.0173944  1
2017 Butcher NJ, Horne MK, Mellick GD, Fowler CJ, Masters CL, Minchin RF. Sulfotransferase 1A3/4 copy number variation is associated with neurodegenerative disease. The Pharmacogenomics Journal. PMID 28374858 DOI: 10.1038/tpj.2017.4  0.01
2017 Butcher NJ, Marras C, Pondal M, Rusjan P, Boot E, Christopher L, Repetto GM, Fritsch R, Chow EW, Masellis M, Strafella AP, Lang AE, Bassett AS. Neuroimaging and clinical features in adults with a 22q11.2 deletion at risk of Parkinson's disease. Brain : a Journal of Neurology. PMID 28369257 DOI: 10.1093/Brain/Awx053  1
2016 Voll SL, Boot E, Butcher NJ, Cooper S, Heung T, Chow EW, Silversides CK, Bassett AS. Obesity in adults with 22q11.2 deletion syndrome. Genetics in Medicine : Official Journal of the American College of Medical Genetics. PMID 27537705 DOI: 10.1038/Gim.2016.98  1
2016 Butcher NJ, Mortimer GM, Minchin RF. Drug delivery: Unravelling the stealth effect. Nature Nanotechnology. PMID 26878145 DOI: 10.1038/nnano.2016.6  1
2015 Merico D, Zarrei M, Costain G, Ogura L, Alipanahi B, Gazzellone MJ, Butcher NJ, Thiruvahindrapuram B, Nalpathamkalam T, Chow EW, Andrade DM, Frey BJ, Marshall CR, Scherer SW, Bassett AS. Whole-Genome Sequencing Suggests Schizophrenia Risk Mechanisms in Humans with 22q11.2 Deletion Syndrome. G3 (Bethesda, Md.). 5: 2453-61. PMID 26384369 DOI: 10.1534/G3.115.021345  1
2015 Guna A, Butcher NJ, Bassett AS. Comparative mapping of the 22q11.2 deletion region and the potential of simple model organisms. Journal of Neurodevelopmental Disorders. 7: 18. PMID 26137170 DOI: 10.1186/S11689-015-9113-X  1
2015 Boot E, Butcher NJ, Vorstman JA, van Amelsvoort TA, A Fung WL, Bassett AS. Pharmacological Treatment of 22q11.2 Deletion Syndrome-related Psychoses. Pharmacopsychiatry. PMID 26091278 DOI: 10.1055/S-0035-1554645  1
2015 Van L, Butcher NJ, Costain G, Ogura L, Chow EW, Bassett AS. Fetal growth and gestational factors as predictors of schizophrenia in 22q11.2 deletion syndrome. Genetics in Medicine : Official Journal of the American College of Medical Genetics. PMID 26087175 DOI: 10.1038/Gim.2015.84  1
2015 Butcher NJ, Fung WL, Fitzpatrick L, Guna A, Andrade DM, Lang AE, Chow EW, Bassett AS. Response to clozapine in a clinically identifiable subtype of schizophrenia. The British Journal of Psychiatry : the Journal of Mental Science. 206: 484-91. PMID 25745132 DOI: 10.1192/Bjp.Bp.114.151837  1
2015 Vorstman JA, Breetvelt EJ, Duijff SN, Eliez S, Schneider M, Jalbrzikowski M, Armando M, Vicari S, Shashi V, Hooper SR, Chow EW, Fung WL, Butcher NJ, Young DA, McDonald-McGinn DM, et al. Cognitive decline preceding the onset of psychosis in patients with 22q11.2 deletion syndrome. Jama Psychiatry. 72: 377-85. PMID 25715178 DOI: 10.1001/Jamapsychiatry.2014.2671  1
2015 Boot E, Butcher NJ, van Amelsvoort TA, Lang AE, Marras C, Pondal M, Andrade DM, Fung WL, Bassett AS. Movement disorders and other motor abnormalities in adults with 22q11.2 deletion syndrome. American Journal of Medical Genetics. Part A. 167: 639-45. PMID 25684639 DOI: 10.1002/Ajmg.A.36928  1
2015 Minchin RF, Butcher NJ. The role of lysine(100) in the binding of acetylcoenzyme A to human arylamine N-acetyltransferase 1: implications for other acetyltransferases. Biochemical Pharmacology. 94: 195-202. PMID 25660616 DOI: 10.1016/j.bcp.2015.01.015  1
2015 Tiang JM, Butcher NJ, Minchin RF. Effects of human arylamine N-acetyltransferase I knockdown in triple-negative breast cancer cell lines. Cancer Medicine. 4: 565-74. PMID 25627111 DOI: 10.1002/cam4.415  0.01
2015 Fung WL, Butcher NJ, Costain G, Andrade DM, Boot E, Chow EW, Chung B, Cytrynbaum C, Faghfoury H, Fishman L, García-Miñaúr S, George S, Lang AE, Repetto G, Shugar A, et al. Practical guidelines for managing adults with 22q11.2 deletion syndrome. Genetics in Medicine : Official Journal of the American College of Medical Genetics. PMID 25569435 DOI: 10.1038/Gim.2014.175  1
2014 Merico D, Costain G, Butcher NJ, Warnica W, Ogura L, Alfred SE, Brzustowicz LM, Bassett AS. MicroRNA Dysregulation, Gene Networks, and Risk for Schizophrenia in 22q11.2 Deletion Syndrome. Frontiers in Neurology. 5: 238. PMID 25484875 DOI: 10.3389/Fneur.2014.00238  1
2014 Sidharthan NP, Butcher NJ, Mitchell DJ, Minchin RF. Expression of the orphan cytosolic sulfotransferase SULT4A1 and its major splice variant in human tissues and cells: dimerization, degradation and polyubiquitination. Plos One. 9: e101520. PMID 24988429 DOI: 10.1371/journal.pone.0101520  1
2014 Mortimer GM, Butcher NJ, Musumeci AW, Deng ZJ, Martin DJ, Minchin RF. Cryptic epitopes of albumin determine mononuclear phagocyte system clearance of nanomaterials. Acs Nano. 8: 3357-66. PMID 24617595 DOI: 10.1021/nn405830g  1
2014 Deng ZJ, Butcher NJ, Mortimer GM, Jia Z, Monteiro MJ, Martin DJ, Minchin RF. Interaction of human arylamine N-acetyltransferase 1 with different nanomaterials. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 42: 377-83. PMID 24346836 DOI: 10.1124/dmd.113.055988  1
2014 Merico D, Costain G, Butcher N, Warnica W, Ogura L, Alfred SE, Brzustowicz L, Bassett AS. MicroRNA target genes and risk for schizophrenia in 22q11.2 deletion syndrome Frontiers in Neurology. 5. DOI: 10.3389/Fneur.2014.00221  1
2013 Witham KL, Butcher NJ, Sugamori KS, Brenneman D, Grant DM, Minchin RF. 5-methyl-tetrahydrofolate and the S-adenosylmethionine cycle in C57BL/6J mouse tissues: gender differences and effects of arylamine N-acetyltransferase-1 deletion. Plos One. 8: e77923. PMID 24205029 DOI: 10.1371/Journal.Pone.0077923  1
2013 Sidharthan NP, Minchin RF, Butcher NJ. Cytosolic sulfotransferase 1A3 is induced by dopamine and protects neuronal cells from dopamine toxicity: role of D1 receptor-N-methyl-D-aspartate receptor coupling. The Journal of Biological Chemistry. 288: 34364-74. PMID 24136195 DOI: 10.1074/jbc.M113.493239  1
2013 Butcher NJ, Kiehl TR, Hazrati LN, Chow EW, Rogaeva E, Lang AE, Bassett AS. Association between early-onset Parkinson disease and 22q11.2 deletion syndrome: identification of a novel genetic form of Parkinson disease and its clinical implications. Jama Neurology. 70: 1359-66. PMID 24018986 DOI: 10.1001/Jamaneurol.2013.3646  1
2013 Butcher NJ, Kiehl TR, Hazrati LN. Genetic deletion could increase the risk of early-onset Parkinson's disease Future Neurology. 8: 610. DOI: 10.2217/fnl.13.56  1
2013 Cox J, Markey A, Kohn R, Butcher NJ, Moxon M, Knowles M, Moxham P, Abbott K, Burian B, Richards P, Martin D, Barnett J, Terry P. Smoke, fire and fumes in transport aircraft: Past history, current risk and recommended mitigations International Air Safety Seminar Proceedings. 14-79.  1
2012 Butcher NJ, Chow EW, Costain G, Karas D, Ho A, Bassett AS. Functional outcomes of adults with 22q11.2 deletion syndrome. Genetics in Medicine : Official Journal of the American College of Medical Genetics. 14: 836-43. PMID 22744446 DOI: 10.1038/Gim.2012.66  1
2012 Butcher NJ, Friedrich AB, Lu Z, Tanimoto H, Meinertzhagen IA. Different classes of input and output neurons reveal new features in microglomeruli of the adult Drosophila mushroom body calyx. The Journal of Comparative Neurology. 520: 2185-201. PMID 22237598 DOI: 10.1002/Cne.23037  1
2012 Butcher NJ, Minchin RF. Arylamine N-acetyltransferase 1: a novel drug target in cancer development. Pharmacological Reviews. 64: 147-65. PMID 22090474 DOI: 10.1124/pr.110.004275  1
2011 Sisak K, Dewar D, Butcher N, King K, Evans J, Miller M, Yoshino O, Harrigan P, Bendinelli C, Balogh ZJ. The treatment of traumatic shock: recent advances and unresolved questions. European Journal of Trauma and Emergency Surgery : Official Publication of the European Trauma Society. 37: 567-75. PMID 26815467 DOI: 10.1007/s00068-011-0150-1  0.01
2011 Knowles-Barley S, Butcher NJ, Meinertzhagen IA, Armstrong JD. Biologically inspired EM image alignment and neural reconstruction. Bioinformatics (Oxford, England). 27: 2216-23. PMID 21742636 DOI: 10.1093/Bioinformatics/Btr378  1
2011 Tiang JM, Butcher NJ, Cullinane C, Humbert PO, Minchin RF. RNAi-mediated knock-down of arylamine N-acetyltransferase-1 expression induces E-cadherin up-regulation and cell-cell contact growth inhibition. Plos One. 6: e17031. PMID 21347396 DOI: 10.1371/journal.pone.0017031  1
2011 Mitchell DJ, Butcher NJ, Minchin RF. Phosphorylation/dephosphorylation of human SULT4A1: role of Erk1 and PP2A. Biochimica Et Biophysica Acta. 1813: 231-7. PMID 20920535 DOI: 10.1016/j.bbamcr.2010.09.011  1
2011 Paterson S, Sin KL, Tiang JM, Minchin RF, Butcher NJ. Histone deacetylase inhibitors increase human arylamine N-acetyltransferase-1 expression in human tumor cells. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 39: 77-82. PMID 20870783 DOI: 10.1124/dmd.110.036202  1
2010 Butcher NJ, Mitchell DJ, Burow R, Minchin RF. Regulation of mouse brain-selective sulfotransferase sult4a1 by cAMP response element-binding protein and activating transcription factor-2. Molecular Pharmacology. 78: 503-10. PMID 20571078 DOI: 10.1124/mol.110.063404  1
2010 Butcher NJ, Minchin RF. Arylamine N-acetyltransferase 1 gene regulation by androgens requires a conserved heat shock element for heat shock factor-1. Carcinogenesis. 31: 820-6. PMID 20176657 DOI: 10.1093/carcin/bgq042  1
2010 Tiang JM, Butcher NJ, Minchin RF. Small molecule inhibition of arylamine N-acetyltransferase Type I inhibits proliferation and invasiveness of MDA-MB-231 breast cancer cells. Biochemical and Biophysical Research Communications. 393: 95-100. PMID 20100460 DOI: 10.1016/j.bbrc.2010.01.087  1
2009 Leiss F, Groh C, Butcher NJ, Meinertzhagen IA, Tavosanis G. Synaptic organization in the adult Drosophila mushroom body calyx. The Journal of Comparative Neurology. 517: 808-24. PMID 19844895 DOI: 10.1002/Cne.22184  1
2008 Butcher NJ, Tiang J, Minchin RF. Regulation of arylamine N-acetyltransferases. Current Drug Metabolism. 9: 498-504. PMID 18680469 DOI: 10.2174/138920008784892128  1
2008 Boukouvala S, Westwood IM, Butcher NJ, Fakis G. Current trends in N-acetyltransferase research arising from the 2007 International NAT Workshop. Pharmacogenomics. 9: 765-71. PMID 18518853 DOI: 10.2217/14622416.9.6.765  1
2007 Butcher NJ, Broadhurst GM, Minchin RF. Polyamine-dependent regulation of spermidine-spermine N1-acetyltransferase mRNA translation. The Journal of Biological Chemistry. 282: 28530-9. PMID 17690107 DOI: 10.1074/jbc.M701265200  1
2007 Minchin RF, Hanna PE, Dupret JM, Wagner CR, Rodrigues-Lima F, Butcher NJ. Arylamine N-acetyltransferase I. The International Journal of Biochemistry & Cell Biology. 39: 1999-2005. PMID 17392017 DOI: 10.1016/J.Biocel.2006.12.006  1
2007 Butcher NJ, Tetlow NL, Cheung C, Broadhurst GM, Minchin RF. Induction of human arylamine N-acetyltransferase type I by androgens in human prostate cancer cells. Cancer Research. 67: 85-92. PMID 17210686 DOI: 10.1158/0008-5472.CAN-06-2635  1
2005 Butcher NJ, Arulpragasam A, Goh HL, Davey T, Minchin RF. Genomic organization of human arylamine N-acetyltransferase Type I reveals alternative promoters that generate different 5'-UTR splice variants with altered translational activities. The Biochemical Journal. 387: 119-27. PMID 15487985 DOI: 10.1042/BJ20040903  1
2004 Butcher NJ, Arulpragasam A, Minchin RF. Proteasomal degradation of N-acetyltransferase 1 is prevented by acetylation of the active site cysteine: a mechanism for the slow acetylator phenotype and substrate-dependent down-regulation. The Journal of Biological Chemistry. 279: 22131-7. PMID 15039438 DOI: 10.1074/jbc.M312858200  1
2003 Butcher NJ, Arulpragasam A, Pope C, Minchin RF. Identification of a minimal promoter sequence for the human N-acetyltransferase Type I gene that binds AP-1 (activator protein 1) and YY-1 (Yin and Yang 1). The Biochemical Journal. 376: 441-8. PMID 12946272 DOI: 10.1042/BJ20030650  1
2002 Butcher NJ, Boukouvala S, Sim E, Minchin RF. Pharmacogenetics of the arylamine N-acetyltransferases. The Pharmacogenomics Journal. 2: 30-42. PMID 11990379 DOI: 10.1038/sj.tpj.6500053  1
2000 Butcher NJ, Ilett KF, Minchin RF. Inactivation of human arylamine N-acetyltransferase 1 by the hydroxylamine of p-aminobenzoic acid. Biochemical Pharmacology. 60: 1829-36. PMID 11108798 DOI: 10.1016/S0006-2952(00)00501-3  1
2000 Butcher NJ, Ilett KF, Minchin RF. Substrate-dependent regulation of human arylamine N-acetyltransferase-1 in cultured cells. Molecular Pharmacology. 57: 468-73. PMID 10692486  1
1998 Butcher NJ, Ilett KF, Minchin RF. Functional polymorphism of the human arylamine N-acetyltransferase type 1 gene caused by C190T and G560A mutations. Pharmacogenetics. 8: 67-72. PMID 9511183 DOI: 10.1097/00008571-199802000-00009  1
1996 Butcher NJ, Minchin RF, Kadlubar FF, Ilett KF. Uptake of the food-derived heterocyclic amine carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and its N-hydroxy metabolite into rat pancreatic acini and hepatocytes in vitro. Carcinogenesis. 17: 889-92. PMID 8625507 DOI: 10.1093/Carcin/17.4.889  1
Show low-probability matches.